This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovations of Jean-Jaques Berthelon
Introduction
Jean-Jaques Berthelon is a notable inventor based in Lyon, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzopyrans and benzoxepines. His research focuses on developing compounds that can be utilized in the treatment of various medical conditions.
Latest Patents
Berthelon holds a patent for "Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process." This invention relates to specific chemical compounds that can be used in the treatment of dyslipidemias, atherosclerosis, and diabetes. The patent outlines the formula and preparation processes for these compounds, showcasing Berthelon's expertise in pharmaceutical innovation. He has 1 patent to his name.
Career Highlights
Jean-Jaques Berthelon is currently associated with Merck Patent GmbH, where he continues to advance his research in pharmaceuticals. His work has been instrumental in developing new therapeutic options for patients suffering from metabolic disorders.
Collaborations
Throughout his career, Berthelon has collaborated with esteemed colleagues, including Daniel Guerrier and Michel Brunet. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Jean-Jaques Berthelon exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for critical health issues.